Filament Health Announces Third Quarter 2024 Financial Results And Operational Highlights
These patients are considering MAiD. They say Canada has made it harder to access magic mushrooms — a treatment giving them reason to live
Innovative trial will use psilocybin to target relapse in opioid addiction